Gay City was among three community groups to receive funding this year from the Fred Hutch Health Disparities Research Center. Shown here are community organizer Emmet Stanfield and Kathy Ulrich, development director.
Urban, Hanash and several other early detection researchers are foundation grant recipients
Aug. 30, 2010
| By Christi Ball Loso
The fifth floor of the Arnold Building, which houses the labs of Drs. Nicole Urban and Samir Hanash, has a new name in honor of the Cancary Foundation, which funds the Fred Hutchinson Cancer Research Center’s early cancer detection research.
Public Health Sciences Division finding that biomarkers may show up years ahead of diagnosis is a step forward in early detection efforts
Jan. 11, 2010
Concentrations of three biomarkers begin to rise three years before women are diagnosed ovarian cancer, according to a new study by Fred Hutchinson Cancer Research Center Public Health Sciences Division researchers published online Dec. 30 in the Journal of the National Cancer Institute. However, the study found the biomarkers become substantially elevated only in the last year prior to diagnosis.
New study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy drugs
Feb. 11, 2008
| By Kristen Woodward
A new mechanism, at the Hutchinson Center unlike any previously identified, may help explain why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin.
Simple evaluation of symptoms may be first screening test for ovarian cancer
Jan. 2, 2007
A symptom survey may provide clinicians with a rapid, cost-effective screening tool to detect early stages of ovarian cancer, according to a new study led by Dr. Barbara Goff of the Clinical Research Division of Hutchinson Center, Seattle Cancer Care Alliance and University of Washington School of Medicine.